HRES 484 United States House · 117th Congress

Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

Summary

This resolution expresses the sense of the House of Representatives that the United States should not waive intellectual property protections for COVID-19 vaccines, treatments, or other related innovations.

Issues: ✗ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Jun 2021

Committee Review

Floor Vote

President

Introduced Jun 17, 2021 Last action Nov 1, 2022

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Nov 1, 2022

Committee

Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

lower

Jun 17, 2021

Committee

Referred to the House Committee on the Judiciary.

lower

Jun 17, 2021

Introduced

Introduced in House

lower

1 primary · 23 co-sponsors